Purchase Order VA77016P1528
Award Date 8/19/16
Potential Completion Date 8/29/16
Potential Value $456K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Wayne, PA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, by the Department of Veterans Affairs for NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has a ceiling value of $130,256.64 and is a Firm Fixed Price Delivery Order. It is not a set-aside contract. Emergent Devices, Inc. is a subsidiary of Emergent BioSolutions, a multinational specialty biopharmaceutical company. The company holds multiple...
- The Department of Veterans Affairs Veterans Health Administration awarded a $946,261.44 firm fixed price delivery order to Emergent Devices, Inc. for the provision of naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and is used to treat substance abuse. The contract is placed against Emergent Devices' Federal Supply Schedule 65 IB contract for pharmaceuticals and drugs, which runs through August 2028. The award has no set-aside designation. In addition to...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the provision of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has a ceiling value of $452,280.00 and an ultimate completion date of March 10, 2017. Emergent Devices, Inc. is a subsidiary of Emergent BioSolutions, a multinational specialty biopharmaceutical company. The company holds...
- The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Emergent Devices, Inc. for the provision of naloxone nasal spray. The contract is a Firm Fixed Price Delivery Order with a potential value of $292,572.00. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. Emergent Devices, a for-profit manufacturer, is the prime contractor on this award. The contract is not set aside and is issued under the...
- This is a federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the delivery of naloxone nasal spray. The contract, valued at $904,465.44, was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The contract is a delivery order under Emergent Devices' Federal Supply Schedule 65 IB contract for pharmaceuticals and drugs, which runs through August 2028. Naloxone is a medication used to...
- The Department of Veterans Affairs Veterans Health Administration awarded Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, a firm-fixed-price delivery order contract to provide naloxone nasal spray. The $904,465.44 contract is under the Pharmaceuticals and Drugs Federal Supply Schedule 61-IB, which allows Emergent Devices to furnish drugs and hematology products to VA facilities through 2028. The naloxone nasal spray rapidly reverses opioid overdoses and treats substance...
- This is a federal contract award to Emergent Devices, Inc., a multinational specialty biopharmaceutical company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of naloxone nasal spray, a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract has a potential value of $1,008,582.12 and is a Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract does not...
- This is a federal contract award to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray to the Department of Veterans Affairs Veterans Health Administration. The contract is a $934,875.00 delivery order under Emergent Devices' Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs, which runs through August 2028. The naloxone nasal spray is used to rapidly reverse opioid overdoses and treat substance abuse. Emergent Devices has also received other...
- This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer of pharmaceuticals and medical devices. The $1,017,630.00 contract is for the delivery of naloxone nasal spray, a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract is a Delivery Order placed against Emergent Devices' Federal Supply Schedule (FSS-61-IB) contract for pharmaceuticals and drugs. No...
- This is a federal contract award to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray to the Department of Veterans Affairs Veterans Health Administration. The $946,261.44 delivery order contract is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is for a firm fixed price. The naloxone nasal spray is used to rapidly reverse opioid overdoses and treat substance abuse. Emergent Devices has held other contracts to supply this medication...